$375 Million is the total value of Stanley-Laman Group, Ltd.'s 204 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMRN | New | BIOMARIN PHARMACEUTL | $6,815,000 | – | 73,226 | +100.0% | 1.82% | – |
| ACAD | New | ACADIA PHARMACEUTL | $5,420,000 | – | 143,876 | +100.0% | 1.45% | – |
| NBIX | New | NEUROCRINE BIOSCIENC | $3,396,000 | – | 55,423 | +100.0% | 0.91% | – |
| CYBR | New | CYBERARK SOFTWRE LTD F | $2,249,000 | – | 54,856 | +100.0% | 0.60% | – |
| SANM | New | SANMINA CORPORATION | $1,361,000 | – | 36,628 | +100.0% | 0.36% | – |
| CBM | New | CAMBREX CORP | $1,084,000 | – | 19,710 | +100.0% | 0.29% | – |
| DWDP | New | DOWDUPONT INC | $849,000 | – | 12,263 | +100.0% | 0.23% | – |
| GIMO | New | GIGAMON INC | $741,000 | – | 17,582 | +100.0% | 0.20% | – |
| TWLO | New | TWILIO INC CLASS Acl a | $723,000 | – | 24,234 | +100.0% | 0.19% | – |
| PFPT | New | PROOFPOINT INC | $717,000 | – | 8,220 | +100.0% | 0.19% | – |
| IMPV | New | IMPERVA INC | $675,000 | – | 15,550 | +100.0% | 0.18% | – |
| CTWS | New | CONNECTICUT WTR SVC | $666,000 | – | 11,235 | +100.0% | 0.18% | – |
| MULE | New | MULESOFT INC CLASS Acl a | $655,000 | – | 32,519 | +100.0% | 0.18% | – |
| NUVA | New | NUVASIVE INC | $594,000 | – | 10,714 | +100.0% | 0.16% | – |
| MOBL | New | MOBILEIRON INC | $572,000 | – | 154,545 | +100.0% | 0.15% | – |
| DDS | New | DILLARDS INC CLASS Acl a | $522,000 | – | 9,311 | +100.0% | 0.14% | – |
| NAVG | New | NAVIGATORS GROUP INC | $506,000 | – | 8,669 | +100.0% | 0.14% | – |
| RICK | New | R C I HOSPITALITY HO | $484,000 | – | 19,563 | +100.0% | 0.13% | – |
| MWA | New | MUELLER WATER PRODUC | $327,000 | – | 25,515 | +100.0% | 0.09% | – |
| SGEN | New | SEATTLE GENETICS INC | $214,000 | – | 3,940 | +100.0% | 0.06% | – |
| CL | New | COLGATE-PALMOLIVE CO | $207,000 | – | 2,839 | +100.0% | 0.06% | – |
| OPK | New | OPKO HEALTH INC | $89,000 | – | 13,000 | +100.0% | 0.02% | – |
| SYN | New | SYNTHETIC BIOLOGICS | $56,000 | – | 60,323 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| APPLE INC | 40 | Q3 2023 | 1.4% |
| ABBVIE INC | 40 | Q3 2023 | 4.2% |
| C V S HEALTH CORPORATION | 39 | Q3 2023 | 0.9% |
| UNITEDHEALTH GRP INC | 38 | Q3 2023 | 0.9% |
| EAGLE PHARMACEUTICALS | 37 | Q3 2023 | 0.7% |
| MICROSOFT CORP | 36 | Q3 2023 | 2.1% |
| BOEING CO | 36 | Q3 2023 | 1.0% |
| HONEYWELL INTL INC TRADES WITH DUE BILLS | 34 | Q3 2023 | 0.8% |
| LYONDELLBASELL INDS F DUTCH TENDER EXP: 07/08/19 | 34 | Q3 2023 | 0.6% |
| JOHNSON & JOHNSON | 34 | Q3 2023 | 0.5% |
View Stanley-Laman Group, Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-17 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-10-16 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-04-18 |
| 13F-HR | 2023-01-19 |
| 13F-HR | 2022-10-18 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-04-21 |
| 13F-HR | 2022-01-25 |
View Stanley-Laman Group, Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.